News round-up for 31 March – 4 April by DDW Senior Digital Content Editor Diana Spencer.
The headlines this week have demonstrated the importance of antibody therapies, particularly in treating cancer, but also as potential therapeutics for a range of other diseases including hepatitis D and Alzheimer’s.
The top stories:
Trial investigates monoclonal antibody for chronic hepatitis D
Bluejay Therapeutics’ AZURE-1 global pivotal clinical trial evaluating brelovitug (BJT-778) for the…
